PARIS, FRANCE, May 8, 2024 – Our CEO, Olivier Courrèges, will be presenting at the HITLAB Summit in New York City this week!
Olivier’s presentation “AI Opening a New Era of Prediction and Monitoring for CNS Diseases.” is scheduled for May 8th at 12:10 PM EST.
Don’t miss out on this insightful session!
For more details, check out the full agenda here.
About Qynapse: Qynapse Inc. is a medical technology company commercializing an AI-powered and proprietary neuroimaging software platform, creating the potential for earlier clinical precision on the frontlines of CNS disease. Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, adds the potential for more precise and objective brain scan analysis. Qynapse is headquartered in France with offices in the US Canada. www.qynapse.com